American Pharmaceutical(APPX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : American Pharmaceutical(APPX)

APPX 36.58

+5.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: MLD38	7/28/2005 12:43:33 PM
	of 22

APPX : SquawkBox, IntraDay Price & Volume, etc On CNBC, an analyst mentioned APPX regarding public companies with Nano related cancer fighting drug delivery systems. His comments were made to expand on an earlier CNBC interview with Ram Sasisekharan of MIT regarding their "in development" new smart bomb for cancer. (see bottom of post) See Squawk Box Guest : 7:00 AM - 10:00 AM ET moneycentral.msn.com IntraDay Price & Volume: Each line is the combination of trades for a 90 sec period 15-20 min Quote Delay host.businessweek.com APPX Report: HyperQuotes tal.marketgauge.com Group: Biotechnology & Drugs : ....At the bottom of the webpage are thumbnail charts including competitors.... Jan 2006 LEAPs: finance.yahoo.com -------------------------------------------------------------------------------- Ram Sasisekharan: Complex Sugars Complicate Biology --- Cell's Microenvironment Key to Cell Behavior See, Novel Drug Delivery Systems Impacting Cancer Research, at the bottom of the webpage. alum.mit.edu ...."In addition to improving existing drugs, Sasisekharan also investigates possible prostate cancer treatments from novel combination therapy drug delivery systems. His studies show that sugars found on both normal and malignant cells determine if the cells remain dormant or if they respond to growth signals and start dividing. Using two off-the-shelf drugs, Sasisekharan's group developed a dual compartment delivery device called a nanocell. The inner core houses a chemotherapeutic drug, the outer core an anti-angiogenesis drug, and the result works something like a smart bomb to carefully orchestrate the release time of the two compartments. Such delivery helps the chemotherapeutic drug target cancer cells, not healthy cells. Animal testing showed that controlled release of drugs had a dramatic impact in survival outcomes, and Sasisekharan is also investigating combination therapy as a treatment for stroke."....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next